Messy Rules For Non‐Biological Complex Drugs Under Fire
Executive Summary
Calls are mounting for the EU to make the centralized procedure mandatory for follow-on versions of non‐biological complex drugs and for better regulatory alignment with the US and other countries.
You may also be interested in...
US FDA Adds Generic Insights On How To Demonstrate Nanomaterials Quality
Document sets final framework for assessing chemistry, manufacturing, controls and bioequivalence of a wide range of nanomaterials with new advice such as focusing analysis on the right therapeutic moiety.
Australian Reform Is Opportunity For International Work-Sharing On Non-Biological Complex Drugs
Plans to streamline the approval of generic medicines in Australia must include measures to ensure that safe and effective similar versions of non-biological complex medicines are available.
Australian Generics Approval Reform Is Opportunity For International Work-Sharing On Non-Biological Complex Drugs
Plans to streamline the approval of generic medicines in Australia must include measures to ensure that safe and effective similar versions of non-biological complex medicines are available.